Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022

Upgrades

For Copa Holdings SA CPA, UBS upgraded the previous rating of Neutral to Buy. In the second quarter, Copa Holdings showed an EPS of $0.32, compared to $0.38 from the year-ago quarter. At the moment, the stock has a 52-week-high of $97.63 and a 52-week-low of $55.25. Copa Holdings closed at $72.94 at the end of the last trading period.
According to UBS, the prior rating for Medpace Holdings Inc MEDP was changed from Sell to Neutral. Medpace Hldgs earned $2.05 in the third quarter, compared to $1.29 in the year-ago quarter. The current stock performance of Medpace Hldgs shows a 52-week-high of $235.72 and a 52-week-low of $126.94. Moreover, at the end of the last trading period, the closing price was at $221.50.
For Teradyne Inc TER, Craig-Hallum upgraded the previous rating of Hold to Buy. For the third quarter, Teradyne had an EPS of $1.15, compared to year-ago quarter EPS of $1.59. At the moment, the stock has a 52-week-high of $167.69 and a 52-week-low of $67.81. Teradyne closed at $82.25 at the end of the last trading period.
HSBC upgraded the previous rating for Ferrari NV RACE from Hold to Buy. For the second quarter, Ferrari had an EPS of $1.45, compared to year-ago quarter EPS of $1.34. At the moment, the stock has a 52-week-high of $271.95 and a 52-week-low of $167.45. Ferrari closed at $197.18 at the end of the last trading period.
According to Barclays, the prior rating for Pinduoduo Inc PDD was changed from Equal-Weight to Overweight. Pinduoduo earned $1.13 in the second quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $73.02 and a 52-week-low of $23.21. At the end of the last trading period, Pinduoduo closed at $53.09.
According to Barclays, the prior rating for Annaly Capital Management Inc NLY was changed from Equal-Weight to Overweight. In the third quarter, Annaly Capital Management showed an EPS of $1.06, compared to $1.12 from the year-ago quarter. The current stock performance of Annaly Capital Management shows a 52-week-high of $32.72 and a 52-week-low of $15.11. Moreover, at the end of the last trading period, the closing price was at $17.84.
For AGNC Investment Corp AGNC, Barclays upgraded the previous rating of Equal-Weight to Overweight. For the third quarter, AGNC Investment had an EPS of $0.84, compared to year-ago quarter EPS of $0.75. At the moment, the stock has a 52-week-high of $15.66 and a 52-week-low of $7.30. AGNC Investment closed at $7.92 at the end of the last trading period.
Raymond James upgraded the previous rating for Renasant Corp RNST from Market Perform to Outperform. In the third quarter, Renasant showed an EPS of $0.79, compared to $0.71 from the year-ago quarter. The current stock performance of Renasant shows a 52-week-high of $40.79 and a 52-week-low of $27.61. Moreover, at the end of the last trading period, the closing price was at $35.58.
According to Credit Suisse, the prior rating for Portland General Electric Co POR was changed from Underperform to Neutral. For the third quarter, Portland Gen Electric had an EPS of $0.65, compared to year-ago quarter EPS of $0.56. The stock has a 52-week-high of $57.03 and a 52-week-low of $41.58. At the end of the last trading period, Portland Gen Electric closed at $44.59.

See all analyst ratings upgrades.

Downgrades

Jefferies downgraded the previous rating for ATI Physical Therapy Inc ATIP from Buy to Hold. In the second quarter, ATI Physical Therapy showed an EPS of $0.05, compared to $0.08 from the year-ago quarter. The current stock performance of ATI Physical Therapy shows a 52-week-high of $3.93 and a 52-week-low of $0.85. Moreover, at the end of the last trading period, the closing price was at $1.03.
For FormFactor Inc FORM, Stifel downgraded the previous rating of Buy to Hold. FormFactor earned $0.24 in the third quarter, compared to $0.40 in the year-ago quarter. The current stock performance of FormFactor shows a 52-week-high of $47.48 and a 52-week-low of $24.26. Moreover, at the end of the last trading period, the closing price was at $27.14.
BTIG downgraded the previous rating for Taylor Morrison Home Corp TMHC from Buy to Neutral. Taylor Morrison Home earned $2.72 in the third quarter, compared to $1.34 in the year-ago quarter. The current stock performance of Taylor Morrison Home shows a 52-week-high of $35.17 and a 52-week-low of $20.05. Moreover, at the end of the last trading period, the closing price was at $26.43.
According to UBS, the prior rating for Seagate Technology Holdings PLC STX was changed from Buy to Neutral. For the first quarter, Seagate Tech Hldgs had an EPS of $0.48, compared to year-ago quarter EPS of $2.35. The current stock performance of Seagate Tech Hldgs shows a 52-week-high of $117.67 and a 52-week-low of $49.62. Moreover, at the end of the last trading period, the closing price was at $53.39.
According to JP Morgan, the prior rating for VF Corp VFC was changed from Neutral to Underweight. In the second quarter, VF showed an EPS of $0.73, compared to $1.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $76.61 and a 52-week-low of $27.03. VF closed at $28.21 at the end of the last trading period.
According to Credit Suisse, the prior rating for 1Life Healthcare Inc ONEM was changed from Outperform to Neutral. 1Life Healthcare earned $0.48 in the second quarter, compared to $0.30 in the year-ago quarter. The current stock performance of 1Life Healthcare shows a 52-week-high of $18.43 and a 52-week-low of $5.94. Moreover, at the end of the last trading period, the closing price was at $17.06.
According to Credit Suisse, the prior rating for Cano Health Inc CANO was changed from Outperform to Neutral. In the second quarter, Cano Health showed an EPS of $0.03, compared to $0.03 from the year-ago quarter. The current stock performance of Cano Health shows a 52-week-high of $9.75 and a 52-week-low of $3.78. Moreover, at the end of the last trading period, the closing price was at $3.82.
According to Morgan Stanley, the prior rating for Meta Platforms Inc META was changed from Overweight to Equal-Weight. For the third quarter, Meta Platforms had an EPS of $1.64, compared to year-ago quarter EPS of $3.22. The current stock performance of Meta Platforms shows a 52-week-high of $199.45 and a 52-week-low of $11.73. Moreover, at the end of the last trading period, the closing price was at $129.82.
According to Cowen & Co., the prior rating for Meta Platforms Inc META was changed from Outperform to Market Perform. Meta Platforms earned $1.64 in the third quarter, compared to $3.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $199.45 and a 52-week-low of $11.73. Meta Platforms closed at $129.82 at the end of the last trading period.
RBC Capital downgraded the previous rating for Masco Corp MAS from Outperform to Sector Perform. Masco earned $0.98 in the third quarter, compared to $0.99 in the year-ago quarter. The current stock performance of Masco shows a 52-week-high of $71.06 and a 52-week-low of $42.33. Moreover, at the end of the last trading period, the closing price was at $45.57.
According to Raymond James, the prior rating for Amedisys Inc AMED was changed from Outperform to Market Perform. In the third quarter, Amedisys showed an EPS of $1.15, compared to $1.53 from the year-ago quarter. The current stock performance of Amedisys shows a 52-week-high of $179.91 and a 52-week-low of $91.15. Moreover, at the end of the last trading period, the closing price was at $105.34.
B. Riley Securities downgraded the previous rating for Century Communities Inc CCS from Buy to Neutral. For the third quarter, Century Communities had an EPS of $4.44, compared to year-ago quarter EPS of $3.63. The stock has a 52-week-high of $82.49 and a 52-week-low of $39.00. At the end of the last trading period, Century Communities closed at $47.03.
According to Needham, the prior rating for Silicon Laboratories Inc SLAB was changed from Buy to Hold. For the third quarter, Silicon Laboratories had an EPS of $1.21, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $211.98 and a 52-week-low of $113.47. At the end of the last trading period, Silicon Laboratories closed at $117.80.
Keefe, Bruyette & Woods downgraded the previous rating for Evercore Inc EVR from Outperform to Market Perform. Evercore earned $2.20 in the third quarter, compared to $3.96 in the year-ago quarter. At the moment, the stock has a 52-week-high of $142.18 and a 52-week-low of $78.67. Evercore closed at $99.65 at the end of the last trading period.
Goldman Sachs downgraded the previous rating for Arco Platform Ltd ARCE from Buy to Neutral. In the second quarter, Arco Platform showed an EPS of $0.08, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.74 and a 52-week-low of $9.90. Arco Platform closed at $11.26 at the end of the last trading period.
According to Keybanc, the prior rating for Meta Platforms Inc META was changed from Overweight to Sector Weight. In the third quarter, Meta Platforms showed an EPS of $1.64, compared to $3.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $199.45 and a 52-week-low of $11.73. Meta Platforms closed at $129.82 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

B. Riley Securities initiated coverage on 5E Advanced Materials Inc FEAM with a Buy rating. The price target for 5E Advanced Materials is set to $20.00. In the fourth quarter, 5E Advanced Materials showed an EPS of $0.30, compared to $0.15 from the year-ago quarter. The current stock performance of 5E Advanced Materials shows a 52-week-high of $49.50 and a 52-week-low of $9.02. Moreover, at the end of the last trading period, the closing price was at $12.22.
With a Buy rating, Citigroup initiated coverage on IDEAYA Biosciences Inc IDYA. The price target seems to have been set at $26.00 for IDEAYA Biosciences. For the second quarter, IDEAYA Biosciences had an EPS of $0.57, compared to year-ago quarter EPS of $0.33. The stock has a 52-week-high of $24.09 and a 52-week-low of $8.14. At the end of the last trading period, IDEAYA Biosciences closed at $16.31.
With an Outperform rating, Raymond James initiated coverage on Mercury Systems Inc MRCY. The price target seems to have been set at $55.00 for Mercury Sys. In the fourth quarter, Mercury Sys showed an EPS of $0.81, compared to $0.73 from the year-ago quarter. The stock has a 52-week-high of $72.28 and a 52-week-low of $40.48. At the end of the last trading period, Mercury Sys closed at $48.03.
Needham initiated coverage on Arcellx Inc ACLX with a Buy rating. The price target for Arcellx is set to $31.00. In the second quarter, Arcellx showed an EPS of $0.88, compared to $36.42 from the year-ago quarter. The stock has a 52-week-high of $26.91 and a 52-week-low of $6.04. At the end of the last trading period, Arcellx closed at $20.27.